Lloyd Bod

9PUBLICATIONS
108CO-AUTHORS
Predictive and prognostic markersTumour immunologyInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 08, 2026
Chemokine Landscapes of the Tumor Microenvironment.

|Aug 07, 2026
Spatial Organization of Tumor-Infiltrating B Cells Informs Immune Checkpoint Inhibitor Response in Claudin 18.2-Expressing Gastric Cancer.

|Dec 08, 2025
Inhibiting B cells enhances the efficacy of STING agonism or immune checkpoint blockade in hepatocellular carcinoma.

Xin Liu, Zelong Liu, Chengzhan Zhu

|Dec 03, 2025
A multimodal atlas of COVID-19 severity identifies hallmarks of dysregulated immunity.

Kamil Slowikowski, Pritha Sen, Christopher V Cosgriff

|May 05, 2025
Inhibiting B-cell-mediated Immunosuppression to Enhance the Immunotherapy Efficacy in Hepatocellular Carcinoma.

Xin Liu, Zelong Liu, Tatsuya Kobayashi

|Sep 15, 2024
The DAV132 colon-targeted adsorbent does not interfere with plasma concentrations of antibiotics but prevents antibiotic-related dysbiosis: a randomized phase I trial in healthy volunteers.

Meriem Messaoudene, Stéphanie Ferreira, Nathalie Saint-Lu

Pageof 2

Frequent Collaborators

2 joint publications

Dan G Duda

2 joint publications

Xin Liu

2 joint publications

Pin-Ji Lei

2 joint publications

Ming Kuang